Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
News
News type
Article
Event
Press release
Region
Japan
EU
Latest news
22nd July 2022
Acticor Biotech obtains "PRIME" status from the European Medicines Agency for glenzocimab in the treatment of stroke
Read more
20th July 2022
Doug Kohrs appointed to Sequana Medical Board of Directors
Read more
19th July 2022
Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update
Read more
5th July 2022
Acticor Biotech announces the issuance of a patent in Europe for glenzocimab, its innovative product for the treatment of cardiovascular emergencies
Read more
5th July 2022
Newton Biocapital is one of the 8 VC Firms Certified for AMED Funding Project to Boost Pharma Ecosystem
Read more
3rd July 2022
Newton Biocapitalは、国立研究開発法人日本医療研究開発機構(AMED)の令和4年度「創薬ベンチャーエコシステム強化事業」において、革新的な技術開発を行う創薬ベンチャーの支援に適した認定ベンチャーキャピタルとして採択されましたのでお知らせします。
Read more
3rd July 2022
Newton Biocapital is proud to announce that it has been certified as a part of “New Drug Discovery Venture Ecosystem Strengthening Project” by AMED (Japan Agency for Medical Research and Development).
Read more
1st July 2022
Ambassador at Belgian Embassy of Japan and we visited PRISM BioLab Co., Ltd. together. We continue being the bridge between Japan and Europe’s best LifeSciences.
Read more
28th June 2022
エディットフォースがCNS領域遺伝子治療で田辺三菱と導出契約、総額200億円以上
Read more
6
7
8
9
10
Sign up
You are added to the list, thank you!